v3.26.1
Share-Based Compensation
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation

10. Share-Based Compensation

Stock Options

A summary of the Company’s stock option activity and related information is as follows:

 

 

Options Outstanding

 

 

 

Number
of Options

 

 

Weighted Average
 Exercise
Price

 

 

Weighted Average Remaining Contractual Term
 (in years)

 

 

Aggregate Intrinsic Value
(in thousands)

 

Options outstanding - December 31, 2025

 

 

2,714,651

 

 

$

15.54

 

 

 

8.52

 

 

$

22

 

Granted

 

 

29,300

 

 

 

3.67

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(27,058

)

 

 

11.02

 

 

 

 

 

 

 

Forfeited

 

 

(23,450

)

 

 

15.58

 

 

 

 

 

 

 

Options outstanding - March 31, 2026

 

 

2,693,443

 

 

$

15.45

 

 

 

8.31

 

 

$

109

 

Options exercisable - March 31, 2026

 

 

1,196,458

 

 

$

18.46

 

 

 

7.88

 

 

$

 

All outstanding options as of March 31, 2026 are expected to vest, subject to forfeitures.

The aggregate intrinsic value is calculated as the difference between the exercise price and the estimated fair value of the Company’s Common Stock as of March 31, 2026.

Restricted Stock Units (RSUs)

RSUs vest based on a service requirement and a liquidity event, which was satisfied upon completion of the Merger, plus service requirement. The following table summarizes RSU activities during the three months ended March 31, 2026:

 

 

 

 

 

 

Number
of Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested balance as of December 31, 2025

 

 

41,376

 

 

$

22.89

 

Granted

 

 

 

 

 

 

Vested and released

 

 

(8,277

)

 

 

22.89

 

Forfeited

 

 

(457

)

 

 

22.89

 

RSUs outstanding - March 31, 2026

 

 

32,642

 

 

$

22.89

 

Unvested balance as of March 31, 2026

 

 

32,642

 

 

$

22.89

 

2024 Employee Stock Purchase Plan

In October 2024, the Board adopted the 2024 Employee Stock Purchase Plan (the “2024 ESPP”), which became effective immediately upon completion of the Merger. The Company recorded approximately $39 and $0 of share-based compensation expense during the three months ended March 31, 2026 and 2025, respectively, related to the 2024 ESPP, which is reflected in the Share-Based Compensation Expense table below.

Share-Based Compensation Expense

The following table shows the allocation of share-based compensation expense related to the Company’s employee and non-employee share-based awards (in thousands):

 

Three Months
Ended March 31,

 

 

2026

 

 

2025

 

Research and development

$

1,284

 

 

$

1,317

 

General and administrative

 

1,496

 

 

 

1,428

 

Total

$

2,780

 

 

$

2,745